Gilead Sciences
GILD
#102
Rank
A$261.36 B
Marketcap
A$210.78
Share price
-0.52%
Change (1 day)
22.37%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): A$11.09

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is A$10.42. In 2025 the company made an earnings per share (EPS) of A$9.62 an increase over its 2024 EPS that were of A$0.53.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$11.0915.3%
2025A$9.621702.63%
2024A$0.53-91.65%
2023A$6.3923.98%
2022A$5.15-25.86%
2021A$6.954850%
2020A$0.14-97.64%
2019A$5.950.9%
2018A$5.9018.71%
2017A$4.97-64.88%
2016A$14.15-18.45%
2015A$17.3655.28%
2014A$11.18296.02%
2013A$2.8217.89%
2012A$2.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.27 17.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.84-82.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.89-72.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$39.63 280.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.33 95.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$13.13 26.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$7.77-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$23.89 129.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$5.02-51.82%๐Ÿ‡บ๐Ÿ‡ธ USA